4//SEC Filing
Marques Tiago 4
Accession 0001213900-25-102677
CIK 0001841330other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:26 PM ET
Size
6.2 KB
Accession
0001213900-25-102677
Insider Transaction Report
Form 4
Marques Tiago
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-24+493,341→ 493,341 totalExercise: $0.71Exp: 2035-10-23→ Common Stock (493,341 underlying)
Footnotes (1)
- [F1]The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875240
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 5:26 PM ET
- Size
- 6.2 KB